Literature DB >> 17220814

Dasatinib (Sprycel) for CML and Ph + ALL.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17220814

Source DB:  PubMed          Journal:  Med Lett Drugs Ther        ISSN: 0025-732X            Impact factor:   1.909


× No keyword cloud information.
  2 in total

1.  Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia.

Authors:  Radhakrishnan Ramchandren; Charles A Schiffer
Journal:  Biologics       Date:  2009-07-13

2.  Ramadan Fasting in a Patient with Chronic Myeloid Leukemia Receiving Nilotinib as Upfront.

Authors:  Husam N Al-Dubai; Mohammed A Yassin; Mohammed A Abdulla; Mahmood S Aldapt; Rola S Ghassoub
Journal:  Case Rep Oncol       Date:  2020-06-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.